Nuo Therapeutics Inc (AURX)
0.75
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nuo Therapeutics Profit Margin (Quarterly): -302.2% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -302.2% |
| December 31, 2023 | -331.5% |
| September 30, 2023 | -340.4% |
| June 30, 2023 | -737.8% |
| March 31, 2023 | -1.40K% |
| December 31, 2022 | -1.30K% |
| September 30, 2022 | -2.39K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -160.0% |
| June 30, 2019 | -1.09K% |
| March 31, 2019 | -1.73K% |
| December 31, 2018 | 45.37% |
| September 30, 2018 | -249.7% |
| June 30, 2018 | -426.7% |
| March 31, 2018 | -419.1% |
| December 31, 2017 | -4.05K% |
| September 30, 2017 | -848.9% |
| Date | Value |
|---|---|
| June 30, 2017 | -2.07K% |
| March 31, 2017 | -979.8% |
| September 30, 2016 | -1.08K% |
| March 31, 2016 | -345.8% |
| December 31, 2015 | -2.62K% |
| September 30, 2015 | -637.5% |
| June 30, 2015 | -30.06% |
| March 31, 2015 | 84.91% |
| December 31, 2014 | |
| September 30, 2014 | -282.8% |
| June 30, 2014 | -486.7% |
| March 31, 2014 | -305.2% |
| December 31, 2013 | -141.4% |
| September 30, 2013 | -147.8% |
| June 30, 2013 | -207.8% |
| March 31, 2013 | -230.4% |
| December 31, 2012 | -182.3% |
| September 30, 2012 | -215.1% |
| June 30, 2012 | -202.3% |
| March 31, 2012 | -156.6% |
| December 31, 2011 | 30.37% |
| September 30, 2011 | -144.0% |
| June 30, 2011 | -56.76% |
| March 31, 2011 | -103.3% |
| December 31, 2010 | -161.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.39K%
Minimum
Sep 2022
-160.0%
Maximum
Sep 2019
-893.7%
Average
-737.8%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -122.6% |
| Electromed Inc | 10.76% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -386.9% |
| Return on Assets | -181.6% |
| Return on Invested Capital | -386.9% |
| Gross Profit Margin (Quarterly) | 78.43% |
| Operating Margin (Quarterly) | -302.4% |
| Return on Net Operating Assets | -398.7% |